ENSURING VALUE-FOR-MONEY AND SERVICE PERFORMANCE OF SYNAPXE'S CRITICAL NATIONAL HEALTH IT SYSTEMS

NOTICE PAPER NO. 1152
NOTICE OF QUESTION FOR ORAL ANSWER
FOR THE SITTING OF PARLIAMENT ON 8 SEPTEMBER 2026

Name and Constituency of Member of Parliament
Dr Haresh Singaraju
Nominated MP

Question No. 2717

To ask the Coordinating Minister for Social Policies and Minister for Health given Synapxe's role as the sole national HealthTech agency (a) how value for money and service performance of critical national health IT systems are assured; (b) how Synapxe's costs and service standards are benchmarked against industry comparators; and (c) how concentration risk in national health IT infrastructure is assessed and mitigated.

Answer

1       Synapxe is the IT corporate function of the public healthcare system. It is not different from banks, airlines, or other major organisations having their own corporate IT function. IT is a core capability of any major organisation and should not be deemed as presenting concentration risk. That said, Synapxe benchmarks its costs and standards against other similar service providers, it is accountable to its Board, the MOHH Board and the Ministry of Health.  It also works with other commercial IT vendors, including based on competitive bidding to ensure value for money procurement.